» Articles » PMID: 9888395

Simultaneous Assessment of Cerebral Hemodynamics and Contrast Agent Uptake in Lesions with Disrupted Blood-brain-barrier

Overview
Publisher Elsevier
Specialty Radiology
Date 1999 Jan 15
PMID 9888395
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to develop a method that eliminates the influence of the T1 relaxation time upon the signal-time course in perfusion-weighted imaging of cerebral lesions with blood-brain-barrier (BBB) disruption. On a 1.5 T whole body clinical magnetic resonance (MR) imager, we implemented a dual-echo RF-spoiled FLASH sequence (TE=6/23.6 ms). We developed a postprocessing routine that allowed to calculate a signal-time course representing only the change in T2* and another one representing only the change in T1. Using this method, we examined 7 patients with various brain lesions showing evidence of BBB disruption. In the signal-time-curves obtained from the early echo we found a distinct signal drop due to the T2* effect. These effects could be eliminated by the correction algorithm yielding a 67% higher signal increase. Correction of the signal-time curve of the late echo yielded a more pronounced maximum signal drop and a decrease in postcontrast signal intensity. We found that without this correction the relative regional cerebral blood volume and the first moment of the concentration-time curve were underestimated by 72% and 22%, respectively. The dual echo-sequence combined with the postprocessing algorithm separates T1 and T2* effects and thus allows to assess cerebral hemodynamics and contrast agent kinetics simultaneously. This method may be a useful tool for characterizing, staging, and therapy monitoring of brain tumors.

Citing Articles

Revisiting the use of proton magnetic resonance spectroscopy in distinguishing between primary and secondary malignant tumors of the central nervous system.

Farche M, Fachinetti N, da Silva L, Matos L, Appenzeller S, Cendes F Neuroradiol J. 2022; 35(5):619-626.

PMID: 35446177 PMC: 9513916. DOI: 10.1177/19714009221083145.


Optimization of Acquisition and Analysis Methods for Clinical Dynamic Susceptibility Contrast MRI Using a Population-Based Digital Reference Object.

Semmineh N, Bell L, Stokes A, Hu L, Boxerman J, Quarles C AJNR Am J Neuroradiol. 2018; 39(11):1981-1988.

PMID: 30309842 PMC: 6239921. DOI: 10.3174/ajnr.A5827.


A Population-Based Digital Reference Object (DRO) for Optimizing Dynamic Susceptibility Contrast (DSC)-MRI Methods for Clinical Trials.

Semmineh N, Stokes A, Bell L, Boxerman J, Quarles C Tomography. 2017; 3(1):41-49.

PMID: 28584878 PMC: 5454781. DOI: 10.18383/j.tom.2016.00286.


Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging.

Fink J, Muzi M, Peck M, Krohn K J Nucl Med. 2015; 56(10):1554-61.

PMID: 26294301 PMC: 4592410. DOI: 10.2967/jnumed.113.131516.


Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.

She D, Xing Z, Zeng Z, Shang X, Cao D Neuroradiology. 2014; 57(3):275-81.

PMID: 25487356 DOI: 10.1007/s00234-014-1475-3.